Gastrointestinal Imaging

Pancreatic Perfusion: Noninvasive Quantitative Assessment with Dynamic Contrast-enhanced MR Imaging without and with Secretin Stimulation in Healthy Volunteers—Initial Results

Purpose: To prospectively quantify pancreatic regional perfusion with dynamic contrast material–enhanced magnetic resonance (MR) imaging by using a one-compartment model and to assess perfusion changes during secretin stimulation in healthy volunteers.

Materials and Methods: The study had institutional review board approval, and written informed consent was obtained. Ten healthy volunteers (five men, five women; mean age, 24.7 years ± 1.9 [standard deviation]; range, 22–29 years) underwent MR imaging pancreatic perfusion studies performed twice without secretin and twice during secretin stimulation. Dynamic contrast-enhanced MR imaging consisted of saturation-recovery T1-weighted turbo-field-echo imaging with peripheral pulse triggering and respiratory tracking. A dose of 0.05 mmol gadodiamide per kilogram of body weight was injected at a rate of 3.5 mL/sec. Regional perfusion parameters were fitted with a one-compartment model. The analysis of variance test for repeated measurements was used to assess differences in pancreatic perfusion without and that with secretin administration.

Results: Significant differences in perfusion parameters between the three pancreatic regions were observed (P < .05). During secretin stimulation, a significant difference was observed only between the body and the tail of the pancreas (P = .02). A significant increase (P = .003) in pancreatic perfusion was observed after secretin administration. Mean pancreatic perfusion was 184 mL/min/100 g of tissue ± 71, 207 mL/min/100 g ± 77, and 230 mL/min/100 g ± 87 without secretin and 342 mL/min/100 g ± 154, 338 mL/min/100 g ± 156, and 373 mL/min/100 g ± 176 after secretin stimulation in the head, body, and tail of the pancreas, respectively. Intraindividual variability was 21% without secretin stimulation and 46% with secretin stimulation.

Conclusion: Dynamic contrast-enhanced MR imaging enables noninvasive quantification of regional pancreatic perfusion in resting conditions and demonstrates the increase in pancreatic perfusion during secretin stimulation in healthy subjects.

© RSNA, 2008

References

  • 1 KuboS, Yamamoto K, Magata Y, et al. Assessment of pancreatic blood flow with positron emission tomography and oxygen-15 water. Ann Nucl Med1991;5(4):133–138. Crossref, MedlineGoogle Scholar
  • 2 D'OnofrioM, Zamboni G, Faccioli N, Capelli P, Pozzi Mucelli R. Ultrasonography of the pancreas. 4. Contrast-enhanced imaging. Abdom Imaging2007;32(2):171–181. Crossref, MedlineGoogle Scholar
  • 3 SofuniA, Iijima H, Moriyasu F, et al. Differential diagnosis of pancreatic tumors using ultrasound contrast imaging. J Gastroenterol2005;40(5):518–525. Crossref, MedlineGoogle Scholar
  • 4 MilesKA, Hayball MP, Dixon AK. Measurement of human pancreatic perfusion using dynamic computed tomography with perfusion imaging. Br J Radiol1995;68(809):471–475. Crossref, MedlineGoogle Scholar
  • 5 BizePE, Platon A, Becker CD, Poletti PA. Perfusion measurement in acute pancreatitis using dynamic perfusion MDCT. AJR Am J Roentgenol2006;186(1):114–118. Crossref, MedlineGoogle Scholar
  • 6 McMenaminDA, Gates LK Jr. A retrospective analysis of the effect of contrast-enhanced CT on the outcome of acute pancreatitis. Am J Gastroenterol1996;91(7):1384–1387. MedlineGoogle Scholar
  • 7 Carmona-SanchezR, Uscanga L, Bezaury-Rivas P, Robles-Diaz G, Suazo-Barahona J, Vargas-Vorackova F. Potential harmful effect of iodinated intravenous contrast agent medium on the clinical course of mild acute pancreatitis. Arch Surg2000;135(11):1280–1284. Crossref, MedlineGoogle Scholar
  • 8 HwangTL, Chang KY, Ho YP. Contrast-enhancement dynamic computed tomography does not aggravate the clinical severity of patients with severe acute pancreatitis. Arch Surg2000;135(3):287–290. Crossref, MedlineGoogle Scholar
  • 9 TajimaY, Matsuzaki S, Furui J, Isomoto I, Hayashi K, Kanematsu T. Dynamic magnetic resonance imaging to evaluate remnant pancreatic fibrosis. Br J Surg2004;91(5):595–600. Crossref, MedlineGoogle Scholar
  • 10 CoenegrachtsK, Van Steenbergen W, De Keyzer F, et al. Dynamic contrast-enhanced MRI of the pancreas: initial results in healthy volunteers and patients with chronic pancreatitis. J Magn Reson Imaging2004;20(6):990–997. Crossref, MedlineGoogle Scholar
  • 11 ToftsPS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusible tracer: standarized quantities and symbols. J Magn Reson Imaging1999;10(3):223–232. Crossref, MedlineGoogle Scholar
  • 12 MaterneR, Smith AM, Peeters F, et al. Assessment of hepatic perfusion parameters with dynamic MRI. Magn Reson Med2002;47(1):135–142. Crossref, MedlineGoogle Scholar
  • 13 PruessmannKP, Weiger M, Scheidegger MB, Boesiger P. SENSE: sensitivity encoding for fast MRI. Magn Reson Med1999;42(5):952–962. Crossref, MedlineGoogle Scholar
  • 14 In den KleefJJ, Cuppen JJ. RLSQ: T1, T2, and rho calculations, combining ratios and least squares. Magn Reson Med1987;5(6):513–524. Crossref, MedlineGoogle Scholar
  • 15 BrixG, Kiessling F, Lucht R, et al. Microcirculation and microvasculature in breast tumors: pharmacokinetic analysis of dynamic MR image series. Magn Reson Med2004;52(2):420–429. Crossref, MedlineGoogle Scholar
  • 16 GuytonAC, Hall JE. Secretory function of the alimentary tract. In: Textbook of medical physiology. 9th ed. Philadelphia, Pa: Saunders,1996; 815–876. Google Scholar
  • 17 HoltonP, Jones M. Some observations on changes in the blood content of the cat's pancreas during activity. J Physiol1960;150:479–488. Crossref, MedlineGoogle Scholar
  • 18 EichelterP, Schenk WG Jr. Hemodynamics of pancreatic secretion: with observations on pancreatic oxygen consumption. Arch Surg1966;93(1):200–207. Crossref, MedlineGoogle Scholar
  • 19 DelaneyJP, Grim E. Influence of hormones and drugs on canine pancreatic blood flow. Am J Physiol1966;211(6):1398–1402. Crossref, MedlineGoogle Scholar
  • 20 ChungRS, Safaie-Shirazi S. The effect of secretin on pancreatic blood flow in the awake and anesthetized dog. Proc Soc Exp Biol Med1983;173(4):620–625. Crossref, MedlineGoogle Scholar
  • 21 WiddisonAL, Karanjia ND, Reber HA. Pancreatic vascular regulation in chronic pancreatitis in cats. Gut1995;36(1):133–136. Crossref, MedlineGoogle Scholar
  • 22 DreilingDA, Messer J. The secretin story. Am J Gastroenterol1978;70(5):455–479. MedlineGoogle Scholar
  • 23 AuneS, Semb LS. The effect of secretin and pancreozymin on pancreatic blood flow in the conscious and anesthetized dog. Acta Physiol Scand1969;76(4):406–414. Crossref, MedlineGoogle Scholar
  • 24 AnnetL, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology2003;229(2):409–414. LinkGoogle Scholar
  • 25 PeetersF, Annet L, Hermoye L, Van Beers BE. Inflow correction of hepatic perfusion measurements using T1-weighted, fast gradient-echo, contrast-enhanced MRI. Magn Reson Med2004;51(4):710–717. Crossref, MedlineGoogle Scholar

Article History

Published in print: 2008